Skip to main content
. 2020 Mar 3;14:613–623. doi: 10.2147/OPTH.S225603

Table 3.

(A) Average Levels of sTNFαRII at All Visits; (B) Difference Between Averages of Significant Effects in Levels of sTNFαRII at All Visits

(A)
Effect Log2 pg/mL
Est. CI95% Est. Est. CI95% for est.
Inf. Sup. Inf. Sup.
Visit V0 6.39 5.971 6.816 84.08 62.746 112.68
V1 5.78 5.354 6.199 54.82 40.909 73.464
V2 6.48 6.059 6.904 89.35 66.672 119.73
V3 5.94 5.515 6.36 61.28 45.726 82.115
(B)
Effect Visit Dif. Log2
(I)−(II)
CI95% Dif. t-value p-value
(I) (II) Inf. Sup.
Visit V0 V1 0.62 0.203 1.032 3.8949 0.001
V2 −0.09 −0.502 0.327 −0.5526 0.9456
V3 0.46 0.042 0.871 2.8812 0.0249
V1 V2 −0.7 −1.119 −0.29 −4.4475 0.0001
V3 −0.16 −0.575 0.254 −1.0137 0.7419
V2 V3 0.54 0.13 0.959 3.4338 0.0049

Note: The bold text represents statistically significant values.

Abbreviations: sTNFαRII, soluble fraction of receptor II of tumor necrosis factor α pg/mL; Log2, log values of sTNFαRII; CI, Confidence Interval; Est, statistic value.